Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Cash Flow Quality Index
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Cash Flow Quality Index of 16.37x as of March 2025. Operating cash flow of CN¥36.65 Million exceeds net income of CN¥2.24 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Jiangxi Fushine Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow Quality Index (2012–2021)
Historical Cash Flow Quality Index for Jiangxi Fushine Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300497 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jiangxi Fushine Pharmaceutical Co Ltd (2012–2021)
Year-by-year earnings quality comparison for Jiangxi Fushine Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 300497 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.83x | CN¥72.32 Million | CN¥39.54 Million | ▲ +54.1% |
| 2020 | 1.19x | CN¥382.35 Million | CN¥322.18 Million | ▲ +7.8% |
| 2019 | 1.10x | CN¥337.91 Million | CN¥306.88 Million | ▲ +20.4% |
| 2018 | 0.91x | CN¥175.91 Million | CN¥192.36 Million | ▼ -24.3% |
| 2017 | 1.21x | CN¥210.72 Million | CN¥174.48 Million | ▲ +10.5% |
| 2016 | 1.09x | CN¥188.53 Million | CN¥172.52 Million | ▲ +38.2% |
| 2015 | 0.79x | CN¥74.01 Million | CN¥93.60 Million | ▲ +34.6% |
| 2014 | 0.59x | CN¥31.39 Million | CN¥53.44 Million | ▼ -53.7% |
| 2013 | 1.27x | CN¥57.22 Million | CN¥45.07 Million | ▼ -19.5% |
| 2012 | 1.58x | CN¥63.20 Million | CN¥40.08 Million | — |